Assessment Plan
The College of Pharmacy assesses the success of its DDD program by measuring student performance, which is the percent of students who pass the courses, and program performance, which is calculated using post-program surveys about students’ satisfaction with the program and their career pathways after graduation.
Mission Statement
The mission of the Master of Science and Graduate Certificate programs in Drug Discovery
and Development (DDD) is to “Train healthcare professionals and researchers in drug
discovery and development to create solutions for a healthier community.”
Mission statement fulfills requirements of degree/certificate program accrediting
organization:
Yes
Assessment Leader(s):
Eric Cheng
Program Description:
The Certificate Program in Drug Discovery and Development (DDD) is designed for new
college graduates, Doctor of Pharmacy (PharmD) students, and other full-time or part-time
students including working professionals seeking to gain a systematic understanding
of how drugs and medicines are discovered and developed, and to increase student’s
understanding of clinical, medical, ethical and regulatory affairs of the DDD process.
This certificate program will enhance the career options or promote the career advancement
of students who complete this program. This program was approved in 2020 by the Board
of Regents of the University of North Texas System. This certificate program can be
completed within one to two years, depending on individual student’s schedule and
engagement level.
Program Goal:
This certificate program will enhance student’s career opportunities and promote their
career advancement.
Accrediation:
Assessment Responsibilities:
This program is currently overseen by a Program Director (Dr. Eric Y. Cheng, Professor
of Pharmaceutical Sciences in the UNT Health College of Pharmacy), who coordinates
all aspects of the program including development of an assessment plan and execution
of assessments.
Assessment Process:
Program Outcomes
Assessment Method(s)
Student Learning Outcome 1:
Upon program completion students can effectively describe the research and development
(R & D) aspects of the drug discovery and development (DDD) process.
Exams, quizzes, assignments
Is the Measure Direct / Indirect?
Direct
Description of Assessment
Course-embedded assessments tied to course-specific learning outcomes, including quizzes,
exams and/or assignments, in PHAR 7320/5310, PHAR 7222/5311, and PHAR 7310/5315 (and
PHAR 7112/5112 if applicable)
Criteria for Achievement
On average, 90% of students can effectively describe the R & D aspects of the DDD
process, as measured by passing all related courses.
Time Table
End of each course
Responsible Individual
Course Directors
Assessment Method(s)
Student Learning Outcome 2:
Upon program completion students can effectively summarize the clinical, medical,
legal, ethical and regulatory aspects of the DDD process.
Exams, quizzes, assignments
Is the Measure Direct / Indirect?
Direct
Description of Assessment
Course-embedded assessments ties to course-specific learning outcomes, including quizzes,
exams and/or assignments, in PHAR 7222/5310, PHAR 7382/5314, and PHAR 7310/5315.
Criteria for Achievement
On average, 90% of students can effectively and concisely summarize the clinical,
medical, legal, ethical and regulatory aspects of the DDD process, as measured by
passing all related courses.
Time Table
End of each course
Responsible Individual
Course Directors
Assessment Method(s)
Student Learning Outcome 3:
Upon program completion students can effectively conduct and present a comprehensive
review of an FDA-approved new drug.
Exams, quizzes, assignments
Is the Measure Direct / Indirect?
Direct
Description of Assessment
Course-embedded assessments tied to course-specific learning outcomes, including writing
a drug review and presenting the findings, in PHAR 7310/5315
Criteria for Achievement
On average, 90% of students can effectively conduct and present a comprehensive review
of an FDA-approved new drug, as measured by passing PHAR 7310/5315.
Time Table
End of each course
Responsible Individual
Course Director
Assessment Method(s)
Program Performance Outcome 1:
Student satisfaction with program curriculum and resources
Survey
Is the Measure Direct / Indirect?
Indirect
Description of Assessment
Program completion survey
Criteria for Achievement
Achieve a minimum response rate of 80% among newly graduated students, and 80% of
survey respondents will choose “Meets Expectations” or “Exceeds Expectations”.
Time Table
Six months post program completion
Responsible Individual
UNT Health Division of Student Affairs; Program Director
Assessment Method(s)
Program Performance Outcome 2:
For students who completed the program, report being hired, promoted, or continuing
education in the field of DDD.
Survey
Is the Measure Direct / Indirect?
Indirect
Description of Assessment
Post-program survey
Criteria for Achievement
Achieve a minimum response rate of 50% among students who completed the program, and
50% of survey respondents will report being hired, promoted or continuing education
in the field of DDD.
Time Table
Two years post program completion
Responsible Individual
Program Director